The role of vitamin D and SLCO1B1*5 gene polymorphism in statin-associated myalgias

Dermato-Endocrinology

Volumn 2, Issue 2, 2010, Pages 77-84

  Linde, Randy ^a   Peng, Lihong ^a   Desai, Manisha ^a   Feldman, David ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Myalgias; SLCO1B1 genotype; SNPs; Statin; Vitamin D; Vitamin D deficiency

Indexed keywords

25 HYDROXYVITAMIN D; ATORVASTATIN; COLECALCIFEROL; DILTIAZEM; ERGOCALCIFEROL; FENOFIBRATE; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; NICOTINIC ACID; ORGANIC ANION TRANSPORTER 2; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN; VERAPAMIL;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DRUG TOLERABILITY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MYALGIA; RETREATMENT; RETROSPECTIVE STUDY; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

EID: 78751541922     PISSN: 19381972     EISSN: 19381980     Source Type: Journal    
DOI: 10.4161/derm.2.2.13509     Document Type: Article

References (44)

1. Joy TR, Hegele RA. Narrative review: Statin-related myopathy. Ann Intern Med 2009; 150:858-68.
2. Mohaupt MG, Karas RH, Babiychuk EB, Sanchez- Freire V, Monastyrskaya K, Iyer L, et al. Association between statin-associated myopathy and skeletal muscle damage. CMAJ 2009; 181:11-8.
3. Thompson PD, Clarkson P, Karas RH. Statin-associated myopathy. JAMA 2003; 289:1681-90.
4. Hansen KE, Hildebrand JP, Ferguson EE, Stein JH. Outcomes in 45 patients with statin-associated myopathy. Arch Intern Med 2005; 165:2671-6.
5. Nichols GA, Koro CE. Does statin therapy initiation increase the risk for myopathy? An observational study of 32,225 diabetic and nondiabetic patients. Clin Ther 2007; 29:1761-70.
6. Jacobson TA. Toward "pain-free" statin prescribing: clinical algorithm for diagnosis and management of myalgias. Mayo Clin Proc 2008; 83:687-700.
7. Tangpricha V, Pearce EN, Chen TC, Holick MF. Vitamin D insufficiency among free-living healthy young adults. Am J Med 2002; 112:659-62.
8. Calvo MS, Whiting SJ. Prevalence of vitamin D insufficiency in Canada and the United States: importance to health status and efficacy of current food fortification and dietary supplement use. Nutr Rev 2003; 61:107-13.
9. Calvo MS, Whiting SJ, Barton CN. Vitamin D intake: a global perspective of current status. J Nutr 2005; 135:310-6.
10. Boland R. Role of vitamin D in skeletal muscle function. Endocr Rev 1986; 7:434-48.
11. Holick MF. Vitamin D Deficiency. N Engl J Med 2007; 357:266-81.
12. Ceglia L. Vitamin D and skeletal muscle tissue and function. Mol Aspects Med 2008; 29:407-14.
13. Feldman D, Malloy PJ, Krishnan AV, Balint E. Vitamin D: biology, action and clinical implications. In: Marcus R, Feldman D, Nelson DA, Rosen CJ, Eds. Osteoporosis (third Ed.), San Diego: Academic Press 2007; 317-82.
14. 3 receptors and hormonal responses in cloned human skeletal muscle cells. Endocrinology 1986; 119:2214-20.
15. 3. Trends Endocrinol Metab 2005; 16:280-7.
16. Francis RM, Selby PL. Osteomalacia. Balliere's Clin Endocrinol Metab 1997; 11:145-63.
17. Plotnikoff GA, Quigley JM. Prevalence of severe hypovitaminosis D in patients with persistent, nonspecific musculoskeletal pain. Mayo Clin Proc 2003; 78:1463-70.
18. Pettifor JM. Vitamin D deficiency and nutritional rickets in children. In: Feldman D, Pike JW, Glorieux FH, Eds. Vitamin D. 2nd Ed. Boston: Elsevier Academic Press 2005; 1065-84.
19. Badsha H, Daher M, Ooi Kong K. Myalgias or non-specific muscle pain in Arab or Indo-Pakistani patients may indicate vitamin D deficiency. Clin Rheumatol 2009; 28:971-3.
20. Duell PB, Connor WE. Vitamin D deficiency is associated with myalgias in hyperlipidemic subjects taking statins. Circulation 2008; 118:470.
21. Ahmed W, Khan N, Glueck CJ, Pandey S, Wang P, Goldenberg N, et al. Low serum 25 (OH) vitamin D levels (<32 ng/mL) are associated with reversible myositis- myalgia in statin-treated patients. Translational Research 2009; 153:11-6.
22. Bittner V, Wenger NK, Waters DD, DeMicco DA, Messig M, LaRosa JC. Vitamin D levels are not related to myalgias in statin-treated patients with stable coronary disease. J Am Coll Cardiol 2010; 55:177-1659.
23. Lee JH, O'Keefe JH, Bell D, Hensrud DD, Holick MF. Vitamin D deficiency; an important, common and easily treatable cardiovascular risk factor. J Am Coll Cardiol 2008; 52:1949-56.
24. The Search Collaborative Group. Link E, Parish S, Armitage J, Bowman L, Heath S, Matsuda F, et al. SLCO1B1 variants and statin-induced myopathy - a genomewide study. N Engl J Med 2008; 359:789-99.
25. Seithel A, Glaeser H, Fromm MF, Konig J. The functional consequences of genetic variations in transporter genes encoding human organic anion-transporting polypeptide family members. Expert Opin Drug Metab Toxicol 2008; 4:51-64.
26. Voora D, Shah SH, Spasojevic I, Ali S, Reed CR, Salisbury BA, Ginsburg GS. The SLCO1B1*5 genetic variant is associated with statin-induced side effects. J Am Coll Cardiol 2009; 54:1609-16.
27. Rossi JS, McLeod HL. The pharmacogenetics of statin therapy; when the body aches the mind will follow. J Am Coll Cardiol 2009; 54:1617-8.
28. Zair ZM, Eloranta JJ, Stieger B, Kullak-Ublick GA. Pharmacogenetics of OATP (SLC21/SLCO), OAT and OCT (SLC22) and PEPT (SLC15) transporters in the intestine, liver and kidney. Pharmacogenomics 2008; 9:597-624.
29. Knoblauch H, Schoewel V, Rosada A, Spuler S. Another side to statin-related side effects. Ann Intern Med 2010; 152:478-9.
30. Ghatak A, Faheem O, Thompson PD. The genetics of statin-induced myopathy. Atherosclerosis 2010; 210:337-43.
31. Yavuz B, Ertugrul DT, Cil H, Ata N, Akin KO, Yalcin AA, et al. Increased levels of 25 hydroxyvitamin D and 1,25-dihydroxyvitamin D after rosuvastatin treatment: a novel pleiotropic effect of statins? Cardiovasc Drugs Ther 2009; 23:295-9.
32. Perez-Castrillon JL, Vega G, Abad L, Sanz A, Chaves J, Hernandez G, Duenas A. Effects of Atorvastatin on vitamin D levels in patients with ischaemic heart disease. Am J Card 2007; 99:903-5.
33. Rejnmark L, Vestergaard P, Heickendorff L, Mosekilde L. Simvastatin does not affect vitamin D status, but low vitamin D levels are associated with dyslipidemia; results from a randomized, controlled trial. Int J Endocrinol 2010; 957174:1-6.
34. Grimes DS. Statins and Vitamin D. Cardiovasc Drugs Ther 2009; 23:261-2.
35. Schwartz JB. Effects of vitamin D supplementation in atorvastatin-treated patients: a new drug interaction with an unexpected consequence. Clin Pharmacol Ther 2009; 85:198-203.
36. 2 vitamin D inhibits foam cell formation and suppresses macrophage cholesterol uptake in patients with type 2 diabetes mellitus. Circulation 2009; 120:687-98.
37. Zittermann A, Schleithoff SS, Koerfer R. Putting cardiovascular disease and vitamin D insufficiency into perspective. Br J Nutr 2005; 94:483-92.
38. Giovannucci E, Liu Y, Hollis BW, Rimm EB. 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med 2008; 168:1174-80.
39. Pittas AG, Chung M, Trikalinos T, Mitri TJ, Brendel M, Patel K, et al. Systematic review: vitamin D and cardiometabolic outcomes. Ann Intern Med 2010; 152:307-14.
40. Wang L, Manson JE, Song Y, Sesso HD. Systematic review: vitamin D and calcium supplementation in prevention of cardiovascular events. Ann Intern Med 2010; 152:307-14.
41. Ordovas J, Stranges JS. Vitamin D supplementation in the age of lost innocence. Ann Intern Med 2010; 152:327-9.
42. Bischoff-Ferrari HA, Giovannucci E, WilleT/T WC, Dietrich T, Dawson-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 2006; 84:18-28. [Erratum, Am J Clin Nutr 2006; 84:1253}.
43. Peng L, Malloy PJ, Wang J, Feldman D. Growth inhibitory concentrations of androgens upregulate insulin-like growth factor binding protein-3 expression via an androgen response element in LNCaP human prostate cancer cells. Endocrinology 2006; 147:4599-607.
44. Malloy PJ, Wang J, Peng L, Nayak S, Sisk JM, Thompson CC, Feldman D. A unique insertion/ duplication in the VDR gene that truncates the VDR causing hereditary 1,25-dihydroxyvitamin D-resistant rickets without alopecia. Arch Biochem Biophys 2006; 460:285-92.